Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 51, 949-953, February 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogawa, O.
Right arrow Articles by Yoshida, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogawa, O.
Right arrow Articles by Yoshida, O.

Allelic Loss at Chromosome 3p Characterizes Clear Cell Phenotype of Renal Cell Carcinoma1

Osamu Ogawa, Yoshiyuki Kakehi, Katsuhiko Ogawa, Masahiro Koshiba, Taketoshi Sugiyama and Osamu Yoshida2

Departments of Urology [O. O., Y. K., O. Y.], Geriatric Medicine [M. K.], and Pathology [K. O., T. S.], Faculty of Medicine, Kyoto University, Shogoin-kawahara-cho 54, Sakyo-ku, Kyoto 606, Japan

Incidence of the loss of heterozygosity on chromosome 3p was evaluated using 7 polymorphic probes in 35 Japanese patients with sporadic renal cell carcinoma (RCC). Overall frequency of the loss of heterozygosity on 3p was 53%, representing 16 of 30 informative cases. Examination of the relationship between histopathological phenotypes of RCC and incidence of the 3p loss revealed that the loss of heterozygosity in clear cell type tumors (75%, 12 of 16) was significantly (P < 0.01) more frequent than that in granular cell type tumors (14%, 1 of 7). In addition, three mixed cell type tumors, consisting predominantly of granular cell components, showed no loss of chromosome 3p loci. These findings may support the notion that the loss of heterozygosity on chromosome 3p is a nonrandom event in the tumorigenesis of sporadic RCC, and suggest that this type of chromosomal rearrangement is specific to the clear cell phenotype of RCC.

1 This research was funded by Grants-in-Aid for Cancer Research from the Ministry of Health and Welfare of Japan.

2 To whom requests for reprints should be addressed.

Received 8/ 3/90. Accepted 11/13/90.




This article has been cited by other articles:


Home page
RadiologyHome page
P. L. Choyke, G. M. Glenn, M. M. Walther, B. Zbar, and W. M. Linehan
Hereditary Renal Cancers
Radiology, January 1, 2003; 226(1): 33 - 46.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Vecchione, N. Zanesi, G. Trombetta, D. French, P. Visca, T. Pisani, C. Botti, A. Vecchione, C. M. Croce, and R. Mancini
Cervical Dysplasia, Ploidy, and Human Papillomavirus Status Correlate with Loss of Fhit Expression
Clin. Cancer Res., May 1, 2001; 7(5): 1306 - 1312.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1991 by the American Association for Cancer Research.